Search research articles
Contact Us
Filters
Showing results (51-60 of 66) with videos related to
Page
of 7
Sort By:
Clinical Genitourinary Cancer
|
September 7, 2014
Immunohistochemistry to enhance prognostic allocation and guide decision-making of patients with advanced urothelial cancer receiving first-line chemotherapy
Andrea Necchi, Patrizia Giannatempo, Biagio Paolini, et al.
Clinical Genitourinary Cancer
|
July 22, 2014
A prognostic model including pre- and postsurgical variables to enhance risk stratification of primary mediastinal nonseminomatous germ cell tumors: the 27-year experience of a referral center
Andrea Necchi, Patrizia Giannatempo, Salvatore Lo Vullo, et al.
JCO Precision Oncology
|
August 18, 2025
Targeting Cyclin-Dependent Kinase 4 Amplifications: A Pioneering Case of Metastatic Leydig Cell Tumor Responding to Abemaciclib
Amedeo Nuzzo, Marco Barella, Melanie Claps, et al.
Minerva Urology and Nephrology
|
January 27, 2026
Management of monorchid patients with previous testis cancer: the role of frozen sections and the real possibility of testis sparing surgery in a large retrospective series
Sebastiano Nazzani, Ruggero Darisi, Mario Catanzaro, et al.
Urologic Oncology
|
May 20, 2015
Prognostic reclassification of patients with intermediate-risk metastatic germ cell tumors: Implications for clinical practice, trial design, and molecular interrogation
Daniele Raggi, Luigi Mariani, Patrizia Giannatempo, et al.
BJU International
|
March 17, 2020
Optimising the selection of candidates for neoadjuvant chemotherapy amongst patients with node-positive penile squamous cell carcinoma
Marco Bandini, Maarten Albersen, Juan Chipollini, et al.
Urologic Oncology
|
October 4, 2021
Risk factors and survival outcomes for upstaging after inguinal lymph node dissection for cN1 penile squamous cell carcinoma
Nicholas H Chakiryan, Aaron Dahmen, Marco Bandini, et al.
The Journal of Urology
|
May 25, 2021
Patterns of Recurrence following Inguinal Lymph Node Dissection for Penile Cancer: Optimizing Surveillance Strategies
Nicholas H Chakiryan, Aaron Dahmen, Marco Bandini, et al.
The Journal of Urology
|
August 11, 2021
Reply by Authors
Nicholas H Chakiryan, Aaron Dahmen, Marco Bandini, et al.
Urology
|
July 19, 2023
Predicting Limited Survival Following Inguinal Lymph Node Dissection in Penile Cancer: Should We Revisit the Goals of Care?
Lee A Hugar, Taylor C Peak, Mahrukh Naqvi, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 66) with videos related to
Sort By:
Page
of 7
Clinical Genitourinary Cancer
|
September 7, 2014
Immunohistochemistry to enhance prognostic allocation and guide decision-making of patients with advanced urothelial cancer receiving first-line chemotherapy
Andrea Necchi, Patrizia Giannatempo, Biagio Paolini, et al.
Clinical Genitourinary Cancer
|
July 22, 2014
A prognostic model including pre- and postsurgical variables to enhance risk stratification of primary mediastinal nonseminomatous germ cell tumors: the 27-year experience of a referral center
Andrea Necchi, Patrizia Giannatempo, Salvatore Lo Vullo, et al.
JCO Precision Oncology
|
August 18, 2025
Targeting Cyclin-Dependent Kinase 4 Amplifications: A Pioneering Case of Metastatic Leydig Cell Tumor Responding to Abemaciclib
Amedeo Nuzzo, Marco Barella, Melanie Claps, et al.
Minerva Urology and Nephrology
|
January 27, 2026
Management of monorchid patients with previous testis cancer: the role of frozen sections and the real possibility of testis sparing surgery in a large retrospective series
Sebastiano Nazzani, Ruggero Darisi, Mario Catanzaro, et al.
Urologic Oncology
|
May 20, 2015
Prognostic reclassification of patients with intermediate-risk metastatic germ cell tumors: Implications for clinical practice, trial design, and molecular interrogation
Daniele Raggi, Luigi Mariani, Patrizia Giannatempo, et al.
BJU International
|
March 17, 2020
Optimising the selection of candidates for neoadjuvant chemotherapy amongst patients with node-positive penile squamous cell carcinoma
Marco Bandini, Maarten Albersen, Juan Chipollini, et al.
Urologic Oncology
|
October 4, 2021
Risk factors and survival outcomes for upstaging after inguinal lymph node dissection for cN1 penile squamous cell carcinoma
Nicholas H Chakiryan, Aaron Dahmen, Marco Bandini, et al.
The Journal of Urology
|
May 25, 2021
Patterns of Recurrence following Inguinal Lymph Node Dissection for Penile Cancer: Optimizing Surveillance Strategies
Nicholas H Chakiryan, Aaron Dahmen, Marco Bandini, et al.
The Journal of Urology
|
August 11, 2021
Reply by Authors
Nicholas H Chakiryan, Aaron Dahmen, Marco Bandini, et al.
Urology
|
July 19, 2023
Predicting Limited Survival Following Inguinal Lymph Node Dissection in Penile Cancer: Should We Revisit the Goals of Care?
Lee A Hugar, Taylor C Peak, Mahrukh Naqvi, et al.
Page
of 7